206 related articles for article (PubMed ID: 3003124)
1. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts.
Kazlauskas A; DiCorleto PE
J Cell Physiol; 1986 Feb; 126(2):225-36. PubMed ID: 3003124
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.
Fontenay M; Bryckaert M; Tobelem G
J Cell Physiol; 1992 Sep; 152(3):507-19. PubMed ID: 1324246
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the phosphorylation events in membranes from proliferating vs. quiescent endothelial cells.
Kazlauskas A; DiCorleto PE
J Cell Physiol; 1987 Feb; 130(2):228-44. PubMed ID: 3818801
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a high-molecular-weight protein immunoprecipitated by platelet-derived growth factor antisera.
Graves DT; Antoniades HN
J Cell Physiol; 1988 Nov; 137(2):263-71. PubMed ID: 2461374
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication.
Pelletier DB; Boynton AL
J Cell Physiol; 1994 Mar; 158(3):427-34. PubMed ID: 8126067
[TBL] [Abstract][Full Text] [Related]
6. Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors.
Paulsson Y; Karlsson C; Heldin CH; Westermark B
J Cell Physiol; 1993 Oct; 157(1):97-103. PubMed ID: 8408247
[TBL] [Abstract][Full Text] [Related]
7. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Fantl WJ; Williams LT
Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
[TBL] [Abstract][Full Text] [Related]
8. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphotyrosine phosphatases reveals candidate substrates of the PDGF receptor kinase.
Zippel R; Morello L; Brambilla R; Comoglio PM; Alberghina L; Sturani E
Eur J Cell Biol; 1989 Dec; 50(2):428-34. PubMed ID: 2560717
[TBL] [Abstract][Full Text] [Related]
10. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
11. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.
Escobedo JA; Williams LT
Nature; 1988 Sep; 335(6185):85-7. PubMed ID: 2842689
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 modulates phosphorylation of proteins in human osteoblastic cells.
Kang YM; Yeh YL; Graves DT
J Bone Miner Res; 1995 Jan; 10(1):96-105. PubMed ID: 7747636
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
14. PDGF induction of tyrosine phosphorylation of GTPase activating protein.
Molloy CJ; Bottaro DP; Fleming TP; Marshall MS; Gibbs JB; Aaronson SA
Nature; 1989 Dec; 342(6250):711-4. PubMed ID: 2480526
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
16. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
[TBL] [Abstract][Full Text] [Related]
17. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
19. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
